{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "LEAD: TAMOXIFEN, a hormonal drug taken by thousands of women to help prevent recurrence of breast cancer, may also protect them against heart disease, according to a study reported in the current issue of the Journal of the National Cancer Institute. The two-year study, conducted among 140 women past menopause, showed that the medication helped reduce their blood levels of cholesterol and especially of harmful LDL cholesterol.", "headline": {"main": "Breast Cancer Drug May Benefit the Heart"}, "abstract": null, "print_page": "10", "word_count": 768, "_id": "4fd197558eb7c8105d6a55c3", "snippet": "LEAD: TAMOXIFEN, a hormonal drug taken by thousands of women to help prevent recurrence of breast cancer, may also protect them against heart disease, according to a study reported in the current issue of the Journal of the National Cancer Institute....", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1990/08/21/science/breast-cancer-drug-may-benefit-the-heart.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "WISCONSIN, UNIVERSITY OF"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "BREAST"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "TAMOXIFEN (DRUG)"}], "byline": null, "document_type": "article", "pub_date": "1990-08-21T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "LEAD: INCREASING use of a controversial statistical method to evaluate medical therapies and surgical procedures is beginning to affect profoundly the care of pregnant women and patients with cancer, heart disease and many other common conditions.", "headline": {"main": "New Method of Analyzing Health Data Stirs Debate"}, "abstract": null, "print_page": "1", "word_count": 2181, "_id": "4fd1baed8eb7c8105d6e5287", "snippet": "LEAD: INCREASING use of a controversial statistical method to evaluate medical therapies and surgical procedures is beginning to affect profoundly the care of pregnant women and patients with cancer, heart disease and many other common conditions.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1990/08/21/science/new-method-of-analyzing-health-data-stirs-debate.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "STATISTICS"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "SURGERY AND SURGEONS"}], "byline": {"person": [{"firstname": "Lawrence", "middlename": "K.", "lastname": "ALTMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By LAWRENCE K. ALTMAN"}, "document_type": "article", "pub_date": "1990-08-21T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "Summary", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "LEAD: INTERNATIONAL A3-17 Iraq appealed for peace with Iran, accepting virtually all of Teheran's conditions to settle the issues remaining from their eight-year war. The move underscores Baghdad's growing sense of isolation. Page A1", "headline": {"main": "NEWS SUMMARY"}, "abstract": null, "print_page": "2", "word_count": 1172, "_id": "4fd1baf28eb7c8105d6e56ea", "snippet": "LEAD:    INTERNATIONAL    A3-17       Iraq appealed for peace with Iran, accepting virtually all of Teheran's conditions to settle the issues remaining from their eight-year war. The move underscores Baghdad's growing sense of isolation.    Page A1", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1990/08/16/nyregion/news-summary-451590.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "NO INDEX TERMS"}], "byline": null, "document_type": "article", "pub_date": "1990-08-16T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "LEAD: As reports mount that the nation's most widely prescribed antidepressant drug may spark violent or suicidal behavior in a fraction of patients, lawyers and former users of the medication are banding together to file multimillion-dollar lawsuits against the drug's maker.", "headline": {"main": "Eli Lilly Facing Million-Dollar Suits On Its Antidepressant Drug Prozac", "kicker": "HEALTH"}, "abstract": null, "print_page": "13", "word_count": 1915, "_id": "4fd198178eb7c8105d6a7232", "snippet": "LEAD: As reports mount that the nation's most widely prescribed antidepressant drug may spark violent or suicidal behavior in a fraction of patients, lawyers and former users of the medication are banding together to file multimillion-dollar lawsuits...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1990/08/16/us/health-eli-lilly-facing-million-dollar-suits-on-its-antidepressant-drug-prozac.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "HEALTH PAGE (NYT)"}, {"name": "organizations", "value": "LILLY, ELI, & CO"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "PROZAC (DRUG)"}, {"name": "subject", "value": "DEPRESSION (MENTAL)"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "DAMAGE SUITS"}, {"name": "subject", "value": "SUICIDES AND SUICIDE ATTEMPTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Natalie", "lastname": "ANGIER"}], "original": "By NATALIE ANGIER"}, "document_type": "article", "pub_date": "1990-08-16T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Financial Desk", "lead_paragraph": "LEAD: After years of false starts, the genetically engineered hormone known as alpha interferon is back on the road toward commercial success.", "headline": {"main": "Return of an Ex-Wonder Drug"}, "abstract": null, "print_page": "1", "word_count": 1549, "_id": "4fd196858eb7c8105d6a3eb1", "snippet": "LEAD: After years of false starts, the genetically engineered hormone known as alpha interferon is back on the road toward commercial success.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1990/08/16/business/return-of-an-ex-wonder-drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "HORMONES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "INTERFERON"}, {"name": "subject", "value": "GENETIC ENGINEERING"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By LAWRENCE M. FISHER, Special to The New York Times"}, "document_type": "article", "pub_date": "1990-08-16T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 5, "offset": 0, "time": 46}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}